Oct 22 | Apr 22 | Oct 21 | Apr 21 | |
---|---|---|---|---|
Income Statement | - | |||
Total Revenue | - | - | - | - |
Gross Profit | - | - | - | - |
EBIT | - | - | - | - |
EBITDA | - | - | - | - |
Net Income Common Stockholders | - | - | - | - |
Balance Sheet | - | |||
Cash, Cash Equivalents and Short-Term Investments | $ 345.89K | $ 757.10K | $ 807.58K | $ 367.89K |
Total Assets | $ 660.30K | $ 777.18K | $ 844.78K | $ 385.89K |
Total Debt | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 62.66K | $ 40.02K | $ 21.35K | $ 244.50K |
Stockholders Equity | $ 597.64K | $ 737.16K | $ 823.43K | $ 141.39K |
Cash Flow | - | |||
Free Cash Flow | - | - | - | - |
Operating Cash Flow | - | - | - | - |
Investing Cash Flow | - | - | - | - |
Financing Cash Flow | - | - | - | - |